Assessing lupus
نویسندگان
چکیده
منابع مشابه
Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
After more than 40 years since the first demonstration that high-dose corticosteroids can modify the relentless outcome of lupus nephritis [1], the ideal treatment of lupus nephritis is still far from being established. There is some agreement that the initial treatment should be aggressive, particularly in proliferative forms (so-called induction therapy) and should be followed by a maintenanc...
متن کاملAssessing patients with lupus: towards a drug responder index.
The remarkable diversity of clinical features that are better, the same, or worse than before? Next, the clinician should estimate whether irreversible damage is evident in patients with systemic lupus erythematosus (SLE) demands particular vigilance on the part of the present from the disease or its treatment. Monitoring for drug toxicity is essential to minimize the long-term clinician attemp...
متن کاملNeurobrucellosis in systemic lupus erythematosus
Background: Brucellosis is a zoonotic infection which is endemic in many countries. It is a multisystem disease which may present with a broad spectrum of clinical manifestations and complications. Neurobrucellosis is an uncommon complication of brucellosis. Case presentation: A 25-year-old woman with a history of lupus for 5 months referred to the emergency ward of Shahid Beheshti Hosp...
متن کاملNew Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects.
Systemic lupus erythematosus (SLE) is a multiphenotypic autoimmune disease. The hallmark of SLE is the production of anti-double-stranded DNA autoantibodies and the deposition of immune complexes in target tissues such as the kidney, skin, and brain. Additional phenotypic traits are the presence of arthritis, anemia, central nervous system involvement, and a variety of autoantibodies. Females o...
متن کاملThe importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus.
Treatment of patients with Systemic Lupus Erythematosus (SLE) who have active disease refractory to current therapeutic strategies continues to be a real challenge. Here, we propose that the classic definition of refractory SLE patients - failure to achieve adequate response to the standard of care - should be further refined to incorporate the dimension of adequate drug exposure. Inter-individ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arthritis & Rheumatism
سال: 1998
ISSN: 0004-3591,1529-0131
DOI: 10.1002/1529-0131(199812)41:12<2276::aid-art28>3.3.co;2-p